Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

(Mis)treating the pharmacogenetic incidentalome.

Kohane IS.

Nat Rev Drug Discov. 2012 Feb 1;11(2):89-90. doi: 10.1038/nrd3659.

PMID:
22293554
2.

Pharmacogenetics, pharmacogenomics, and individualized medicine.

Ma Q, Lu AY.

Pharmacol Rev. 2011 Jun;63(2):437-59. doi: 10.1124/pr.110.003533. Epub 2011 Mar 24. Review.

3.

Human genetic variation and personalized medicine.

Agrawal S, Khan F.

Indian J Physiol Pharmacol. 2007 Jan-Mar;51(1):7-28. Review.

PMID:
17877289
4.

Genetic diversity and medicinal drug response in eye care.

Shastry BS.

Graefes Arch Clin Exp Ophthalmol. 2010 Aug;248(8):1057-61. doi: 10.1007/s00417-010-1333-x. Epub 2010 Mar 5. Review.

PMID:
20204657
5.

Pharmacogenetics and personalized medicine.

Li-Wan-Po A.

J Clin Pharm Ther. 2012 Dec;37(6):617-9. doi: 10.1111/jcpt.12010. Epub 2012 Sep 27. No abstract available.

PMID:
23013532
6.

[Pharmacogenetic aspects of current pharmacotherapy].

Slanar O, Zima T.

Cas Lek Cesk. 2010;149(10):472-5. Review. Czech.

PMID:
21121137
7.

Personalized medicine: potential, barriers and contemporary issues.

Sorich MJ, McKinnon RA.

Curr Drug Metab. 2012 Sep 1;13(7):1000-6. Review.

PMID:
22591350
8.

Personalized medicine in psoriasis: concept and applications.

Al-Hoqail IA.

Curr Vasc Pharmacol. 2010 May;8(3):432-6. Review.

PMID:
19758113
9.

[Translational approach for pharmacogenomics and personalized medicine].

Zhang W, Zhou HH.

Yao Xue Xue Bao. 2011 Jan;46(1):1-5. Review. Chinese.

PMID:
21465801
10.

Prospects of personalized medicine in cardiovascular diseases.

Lenfant C.

Metabolism. 2013 Jan;62 Suppl 1:S6-10. doi: 10.1016/j.metabol.2012.08.018. Epub 2012 Sep 21.

PMID:
22999711
11.

Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development.

Alhenc-Gelas F, Parmentier L, Bisagni A.

Therapie. 2003 May-Jun;58(3):275-82. English, French.

PMID:
14655321
12.

Personalizing dermatology: the future of genomic expression profiling to individualize dermatologic therapy.

Rizzo AE, Maibach HI.

J Dermatolog Treat. 2012 Jun;23(3):161-7. doi: 10.3109/09546634.2010.535806. Epub 2011 Jan 22. Review.

PMID:
21254882
13.

Pharmacogenetics and cost-effectiveness analysis: a two-way street.

Chalkidou K, Rawlins M.

Drug Discov Today. 2011 Oct;16(19-20):873-7. doi: 10.1016/j.drudis.2011.08.015. Epub 2011 Aug 30. Review.

PMID:
21903176
14.

The promises of personalized medicine.

Cascorbi I.

Eur J Clin Pharmacol. 2010 Aug;66(8):749-54. doi: 10.1007/s00228-010-0858-6. Epub 2010 Jun 19. No abstract available.

PMID:
20563567
15.

HapMap, pharmacogenomics, and the goal of personalized prescribing.

O'Shaughnessy KM.

Br J Clin Pharmacol. 2006 Jun;61(6):783-6. Review.

16.

Pharmacogenomics: the genomics of drug response.

March R.

Yeast. 2000 Apr;17(1):16-21. Review.

17.

Editorial: SNPs of drug metabolic enzymes and personalized medicine Part II.

Wei DQ, Chen Q.

Curr Drug Metab. 2012 Sep 1;13(7):951. No abstract available.

PMID:
22475268
18.

Priorities and standards in pharmacogenetic research.

Need AC, Motulsky AG, Goldstein DB.

Nat Genet. 2005 Jul;37(7):671-81. Review.

PMID:
15990888
19.

Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics.

Nebert DW, Vesell ES.

Trends Pharmacol Sci. 2006 Nov;27(11):580-6. Epub 2006 Sep 26. Erratum in: Trends Pharmacol Sci. 2007 Feb;28(2):50.

PMID:
17005258
20.

From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics.

Wilffert B, Swen J, Mulder H, Touw D, Maitland-Van der Zee AH, Deneer V; KNMP working group Pharmacogenetics..

Int J Clin Pharm. 2013 Jun;35(3):369-75. doi: 10.1007/s11096-010-9446-1. Epub 2010 Nov 4. Review.

Supplemental Content

Support Center